







IMPORTANT!
THE PRICE OF THE TEST INCLUDES A DNA SAMPLE COLLECTION KIT.
The Apixmed Prism Longevity and Biological Aging genetic test covers 53 markers across seven areas of aging and resilience, including 35 complex markers and 18 individual genetic variants in 19 genes.
A DNA kit for collecting your saliva sample yourself is already included in the price of the test.
Genotyping of the sample in an accredited laboratory.
A report explaining 53 markers and genetic variants in plain language, with an interpretation of the results:
35 polygenic (complex) traits with an explanation of your individual result and what it means;
18 individual genetic variants with an explanation of their possible biological significance.
Context for every marker: genetics is not considered in isolation from lifestyle, age, environment and other factors.
Personalized recommendations on nutrition, physical activity, sleep, lifestyle and preventive approaches.
The option of a consultation with an Apixmed Prism specialist based on your report results.
Pointers to potentially relevant laboratory or clinical parameters that you can discuss with your doctor.
Data protection in line with ISO 27001, GDPR and HIPAA standards.
The Longevity and Biological Aging genetic test covers seven areas, within which it analyzes 35 complex markers and 18 individual genetic variants in 19 genes: from healthspan and molecular aging to bone fragility, brain aging and sensory changes. It assesses how your genetic profile and individual genetic variants are associated with a relatively higher or lower predisposition for each marker compared with a reference population. The test does not measure any marker directly and does not show your biological age — instead it examines the stable genetic context that complements clinical assessment and laboratory tests rather than replacing them.
DNA sample collection is done using saliva. You receive the kit by post and collect your own DNA sample into a special tube — it takes just a few minutes and requires no preparation. The sample is then sent for analysis to an accredited laboratory, and you receive your result in digital format.
35 markers across seven areas. Assessed using polygenic risk scores: tens and hundreds of variants together shape the contribution to a predisposition, and no single one of them determines the picture on its own.
Lifespan, healthspan and integrated aging: exceptional longevity, healthspan, pace of aging
Molecular and cellular aging: telomere length, epigenetic age acceleration, the Klotho protein, catalase, superoxide dismutase activity, thioredoxin
Physical vulnerability, mobility and resilience: frailty index, muscle mass loss, sarcopenia, reduced grip strength in older age, usual walking pace, physical activity, orthostatic hypotension
Brain and cognitive aging: cognitive decline, episodic memory, short-term memory, processing speed, reaction time, dementia, Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, Parkinson's disease
Sensory aging: cataracts, age-related macular degeneration, age-related hearing loss
Bone aging and fractures: bone mineral density, osteoporosis, fractures, hip fracture
Reproductive and visible markers of aging: skin aging, hair graying
18 genetic variants in 19 genes and loci. A mechanistic link to the trait is described for each, so they are interpreted individually and are not included in the complex markers.
FOXO3: cellular stress resistance; a variant of this gene is one of the most reproducible associations with exceptional longevity
CDKN2B-AS1: a locus associated with cardiometabolic aging
CHRNA5: associated with nicotine dependence, one of the main modifiable factors in aging
TERC, TERT, RTEL1, POLD3 and STN1/OBFC1: associated with telomere length
KL-VS: a haplotype of the Klotho gene associated with longevity, inherited as a heterozygote advantage rather than additively
CAT, SOD2 and GPX1: antioxidant defense enzymes, associated with oxidative stress
SLC39A8, GDF5 and TGFA: associated with frailty and joint health in older age
CFH, ARMS2 and C3: associated with age-related macular degeneration
The APOE gene deserves a separate explanation. Its haplotype — the combination of the ε2, ε3 and ε4 variants — is associated with cholesterol levels and, separately, with relative genetic predisposition to cognitive aging and late-onset Alzheimer's disease. This is the best-studied genetic factor of its kind, but carrying the ε4 variant does not mean the disease will necessarily develop: penetrance is incomplete, and a large share of carriers never show clinical signs. Equally, not carrying this variant does not guarantee protection. Given the emotional weight of this information, discussing the decision to take this specific test with a doctor or genetic counselor is worth considering regardless of the result you receive.
Interest in long-term prevention: specific topics for planning regular check-ups as you age.
Family history of dementia or macular degeneration: specific genetic context for a conversation with a neurologist or ophthalmologist.
Active longevity: additional context on physical vulnerability and resilience for a conversation with your doctor.
When choosing supplements: a reason to discuss whether they are appropriate with your doctor, not grounds to change anything on your own.
The Longevity and Biological Aging test is not a diagnosis and does not replace consultation with a doctor.
The results assess probability rather than establishing a predetermined outcome. They are not a diagnosis, do not show your biological age, do not predict lifespan and do not determine treatment. The test does not replace cognitive testing, vision and hearing exams, bone densitometry or consultation with a doctor. Clinical decisions are made by a specialist, taking into account your history, symptoms, age, medication and test results.